KEGG   PATHWAY: pcoq04934
Entry
pcoq04934                   Pathway                                
Name
Cushing syndrome - Propithecus coquereli (Coquerel's sifaka)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
pcoq04934  Cushing syndrome
pcoq04934

Disease
H01431  Cushing syndrome
Organism
Propithecus coquereli (Coquerel's sifaka) [GN:pcoq]
Gene
105804948  E2F1; transcription factor E2F1 [KO:K17454]
105805159  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I [KO:K04856]
105805232  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
105805290  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
105805421  KCNK2; potassium channel subfamily K member 2 [KO:K04913]
105805737  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
105806167  PLCB1; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
105806182  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
105806281  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
105806400  GSK3B; glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
105806461  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
105806548  NR5A1; steroidogenic factor 1 [KO:K08560]
105806950  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
105807089  FZD9; frizzled-9 [KO:K02842]
105807095  ARMC5; armadillo repeat-containing protein 5 [KO:K22499]
105807291  [KO:K00498] [EC:1.14.15.6]
105807305  WDR5B; WD repeat-containing protein 5B [KO:K14963]
105807332  CRHR2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
105807364  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
105807372  [KO:K09047]
105807599  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
105807852  LDLR; low-density lipoprotein receptor [KO:K12473]
105807940  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
105808138  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
105808139  WNT3A; protein Wnt-3a [KO:K00312]
105808252  FZD4; frizzled-4 [KO:K02354]
105808407  RAP1B; ras-related protein Rap-1b [KO:K07836]
105808688  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
105808762  WNT10A; protein Wnt-10a [KO:K01357]
105808766  WNT6; protein Wnt-6 [KO:K00445]
105808848  ADCY7; adenylate cyclase type 7 [KO:K08047] [EC:4.6.1.1]
105809025  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
105809043  [KO:K04353]
105809190  AGTR1; type-1 angiotensin II receptor [KO:K04166]
105809629  HSD3B2; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
105809789  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
105809796  FZD6; frizzled-6 isoform X1 [KO:K02376]
105810199  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
105810284  TCF7L1; transcription factor 7-like 1 [KO:K04490]
105810405  FH; fumarate hydratase, mitochondrial isoform X1 [KO:K01679] [EC:4.2.1.2]
105810548  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
105810592  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
105810783  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
105811104  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
105811299  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
105811413  WNT11; protein Wnt-11 [KO:K01384]
105811873  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
105811965  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
105811984  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 [KO:K09048]
105812010  WNT8A; protein Wnt-8a isoform X1 [KO:K00714]
105812249  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
105812493  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
105812499  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
105812544  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
105812706  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
105812764  ADCY4; adenylate cyclase type 4 [KO:K08044] [EC:4.6.1.1]
105812910  WNT5B; protein Wnt-5b [KO:K00444]
105812929  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H [KO:K04855]
105813177  ADCY9; adenylate cyclase type 9 isoform X1 [KO:K08049] [EC:4.6.1.1]
105813348  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
105813707  RB1; retinoblastoma-associated protein [KO:K06618]
105813715  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
105813943  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
105814259  USP8; ubiquitin carboxyl-terminal hydrolase 8 [KO:K11839] [EC:3.4.19.12]
105814456  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858] [EC:3.1.4.11]
105814579  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
105814677  BRAF; serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
105814865  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
105815218  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 isoform X1 [KO:K04630]
105815312  [KO:K04857]
105815495  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
105815570  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
105815610  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
105815675  WNT4; protein Wnt-4 [KO:K00408]
105815699  E2F2; transcription factor E2F2 [KO:K09389]
105815791  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C isoform X1 [KO:K04850]
105815848  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
105815849  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 [KO:K14964]
105815903  WNT10B; protein Wnt-10b [KO:K01357]
105816027  TCF7; transcription factor 7 isoform X1 [KO:K02620]
105816738  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
105816783  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F isoform X1 [KO:K04853]
105816888  POMC; pro-opiomelanocortin [KO:K05228]
105816916  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
105816960  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
105816977  AIPL1; aryl-hydrocarbon-interacting protein-like 1 [KO:K17767]
105817130  WNT2; protein Wnt-2 [KO:K00182]
105817162  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
105817322  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
105817598  WNT1; proto-oncogene Wnt-1 [KO:K03209]
105817625  KMT2D; histone-lysine N-methyltransferase 2D [KO:K09187] [EC:2.1.1.354]
105817861  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
105817863  [KO:K00513] [EC:1.14.14.16]
105817898  NR4A1; nuclear receptor subfamily 4 group A member 1 isoform X1 [KO:K04465]
105818043  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
105818188  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
105818818  FZD3; frizzled-3 [KO:K02329]
105818927  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta [KO:K04515] [EC:2.7.11.17]
105818969  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
105819072  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
105819075  WNT9B; protein Wnt-9b [KO:K01064]
105819079  WNT3; proto-oncogene Wnt-3 [KO:K00312]
105819233  KMT2A; histone-lysine N-methyltransferase 2A [KO:K09186] [EC:2.1.1.354]
105819434  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
105819437  FZD7; frizzled-7 [KO:K02432]
105819524  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
105820021  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
105820083  [KO:K04632]
105820084  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
105820132  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
105820836  MRAP; LOW QUALITY PROTEIN: melanocortin-2 receptor accessory protein [KO:K22398]
105820951  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
105821032  FZD10; frizzled-10 [KO:K02842]
105821123  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [KO:K04630]
105821215  RBBP5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
105821322  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
105821522  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha [KO:K04515] [EC:2.7.11.17]
105821681  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
105821763  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
105821904  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 [KO:K09048]
105822091  RAP1A; ras-related protein Rap-1A [KO:K04353]
105822110  FZD2; frizzled-2 [KO:K02235]
105822420  AHR; aryl hydrocarbon receptor [KO:K09093]
105822551  APC; adenomatous polyposis coli protein [KO:K02085]
105822607  AXIN1; axin-1 isoform X1 [KO:K02157]
105822738  [KO:K00572]
105823104  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
105823200  AGT; angiotensinogen [KO:K09821]
105823667  FZD8; frizzled-8 [KO:K02375]
105823839  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
105823945  CREB1; cyclic AMP-responsive element-binding protein 1 [KO:K05870]
105823952  FZD5; frizzled-5 [KO:K02375]
105824291  WNT8B; protein Wnt-8b [KO:K00714]
105824322  [KO:K00512] [EC:1.14.14.19 1.14.14.32]
105824424  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
105824685  AXIN2; axin-2 [KO:K04385]
105825335  CTNNB1; catenin beta-1 [KO:K02105]
105825370  CRH; corticoliberin [KO:K05256]
105825452  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma [KO:K04515] [EC:2.7.11.17]
105825562  SCARB1; scavenger receptor class B member 1 [KO:K13885]
105825594  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
105826013  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
105826277  FZD1; frizzled-1 [KO:K02432]
105826535  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
105826706  WDR5; WD repeat-containing protein 5 [KO:K14963]
105826841  WNT7A; protein Wnt-7a [KO:K00572]
105826943  [KO:K04857]
105826973  RASD1; dexamethasone-induced Ras-related protein 1 isoform X1 [KO:K07843]
105826999  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
105827003  CDKN2A; cyclin-dependent kinase inhibitor 2A [KO:K06621]
105827044  [KO:K18437] [EC:3.1.4.53]
105827297  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
105827396  AIP; AH receptor-interacting protein isoform X1 [KO:K17767]
105827423  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
105827468  MEN1; menin isoform X1 [KO:K14970]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
pcoq00020  Citrate cycle (TCA cycle)
pcoq00140  Steroid hormone biosynthesis
pcoq04020  Calcium signaling pathway
pcoq04024  cAMP signaling pathway
pcoq04110  Cell cycle
pcoq04310  Wnt signaling pathway
pcoq04927  Cortisol synthesis and secretion
pcoq04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   

DBGET integrated database retrieval system